Cigna Q4 2024 Earnings Report
Key Takeaways
The Cigna Group reported a revenue increase for Q4 2024, driven by Evernorth Health Services. However, earnings were impacted by higher stop loss medical costs within Cigna Healthcare. The company is addressing these near-term pressures while advancing its long-term growth strategy.
Total revenues for fourth quarter 2024 increased 28% year-over-year.
Shareholders’ net income for fourth quarter 2024 was $1.4 billion, or $5.13 per share.
Adjusted income from operations for fourth quarter 2024 was $1.8 billion, or $6.64 per share.
The Board of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of $6.0 billion in incremental share repurchase authorization.
Cigna
Cigna
Forward Guidance
The Cigna Group projects an adjusted income from operations of at least $29.50 per share for the full year 2025. This outlook includes the impact of expected future share repurchases, anticipated 2025 dividends, and assumes the divestiture of the Company’s Medicare businesses will close in the first quarter of 2025.
Positive Outlook
- Adjusted Revenues2,3 at least $252,000 million
- Adjusted Income from Operations1,2 at least $7,900 million
- Adjusted Income from Operations, per share1,2 at least $29.50
- Cash Flow from Operations2 ~$10,000 million
- Evernorth Adjusted Income from Operations, Pre-Tax1,2 at least $7,200
Challenges Ahead
- Adjusted SG&A Expense Ratio2,4 ~5.4%
- Adjusted Effective Tax Rate2,9 ~19.0%
- Capital Expenditures2 ~$1,400 million
- Shareholder Dividends2 ~$1,600 million
- Cigna Healthcare Adjusted Income from Operations, Pre-Tax1,2 at least $4,100